Empowered Funds LLC acquired a new stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 48,416 shares of the company's stock, valued at approximately $11,073,000. Empowered Funds LLC owned approximately 0.09% of Molina Healthcare as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. 7G Capital Management LLC acquired a new position in Molina Healthcare during the 4th quarter valued at about $1,735,000. BNP Paribas Financial Markets lifted its stake in shares of Molina Healthcare by 63.0% in the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company's stock worth $76,248,000 after acquiring an additional 169,739 shares during the period. Assenagon Asset Management S.A. boosted its holdings in shares of Molina Healthcare by 394.1% in the second quarter. Assenagon Asset Management S.A. now owns 156,632 shares of the company's stock valued at $35,822,000 after acquiring an additional 124,929 shares in the last quarter. Aurora Investment Managers LLC. bought a new position in shares of Molina Healthcare in the first quarter valued at approximately $2,349,000. Finally, Easterly Investment Partners LLC increased its stake in shares of Molina Healthcare by 227.8% during the fourth quarter. Easterly Investment Partners LLC now owns 38,082 shares of the company's stock valued at $6,609,000 after acquiring an additional 26,464 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on MOH. Truist Financial cut their target price on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating for the company in a research report on Friday, July 24th. Mizuho set a $215.00 price target on Molina Healthcare in a research report on Monday, June 8th. UBS Group boosted their price objective on Molina Healthcare from $180.00 to $202.00 and gave the stock a "neutral" rating in a research note on Friday, May 22nd. Wells Fargo & Company cut their price objective on Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating for the company in a report on Tuesday, July 28th. Finally, Sanford C. Bernstein set a $286.00 target price on Molina Healthcare in a research note on Monday, July 13th. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and a consensus price target of $202.44.
Read Our Latest Research Report on MOH
Molina Healthcare Stock Up 0.6%
NYSE MOH opened at $200.03 on Friday. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $244.89. The company has a market capitalization of $10.44 billion, a P/E ratio of -1,111.22, a PEG ratio of 28.66 and a beta of 0.75. The company's 50 day simple moving average is $211.49 and its 200 day simple moving average is $179.63. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion during the quarter, compared to analysts' expectations of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The firm's revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period last year, the firm posted $5.48 earnings per share. Equities research analysts expect that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.